Literature DB >> 28496588

Atrial Septal Defect and Atrial Fibrillation: The Known and Unknown.

George E Blake1, Dhanunjaya Lakkireddy1.   

Abstract

Atrial fibrillation (AF) is a common complication in patients with atrial septal defects (ASDs). The link between AF and ASD is fairly complex and entails modifications in electrophysiologic, contractile and structural properties, at the cellular and tissue level, of both atria, mainly due to chronic atrial stretch and dilation. Surgical repair or percutaneous closure of ASDs are equally effective in reducing mortality and symptoms but limited in preventing or curbing AF, unless combined with an arrhythmia-specific procedure. Transesophageal echocardiography (TEE) and intracardiac echocardiography (ICE) have improved the safety and success of the above procedures. Finally, clearer understanding of the pathophysiology of AF in patients with ASD (and CHF, in general) has led to target-specific advances in medical management.

Entities:  

Year:  2008        PMID: 28496588      PMCID: PMC4956373          DOI: 10.4022/jafib.45

Source DB:  PubMed          Journal:  J Atr Fibrillation        ISSN: 1941-6911


  143 in total

1.  [Permanent rhythm and conduction disorders in patients surgically treated for atrial septal defect].

Authors:  A Medeiros; P Iturralde; M Márquez; S Ramírez; A de Micheli; M Guevara; A Buendía
Journal:  Arch Inst Cardiol Mex       Date:  2000 Jan-Feb

2.  Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort.

Authors:  D Li; S Fareh; T K Leung; S Nattel
Journal:  Circulation       Date:  1999-07-06       Impact factor: 29.690

3.  Some observations on the mechanism of pressure related atrial fibrillation.

Authors:  D A Sideris; S T Toumanidis; M Thodorakis; K Kostopoulos; E Tselepatiotis; C Langoura; T Stringli; S D Moulopoulos
Journal:  Eur Heart J       Date:  1994-11       Impact factor: 29.983

Review 4.  Ionic remodeling in the heart: pathophysiological significance and new therapeutic opportunities for atrial fibrillation.

Authors:  S Nattel; D Li
Journal:  Circ Res       Date:  2000-09-15       Impact factor: 17.367

Review 5.  Atrial fibrillation--a review of course and prognosis.

Authors:  P Petersen; J Godtfredsen
Journal:  Acta Med Scand       Date:  1984

6.  Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/Paisley study.

Authors:  S Stewart; C L Hart; D J Hole; J J McMurray
Journal:  Heart       Date:  2001-11       Impact factor: 5.994

7.  Intracardiac echo-guided radiofrequency catheter ablation of atrial fibrillation in patients with atrial septal defect or patent foramen ovale repair: a feasibility, safety, and efficacy study.

Authors:  Dhanunjaya Lakkireddy; Umamahesh Rangisetty; Subramanya Prasad; Atul Verma; Mazda Biria; Loren Berenbom; Rhea Pimentel; Martin Emert; Thomas Rosamond; Tamer Fahmy; Dimpi Patel; Luigi Di Biase; Robert Schweikert; David Burkhardt; Andrea Natale
Journal:  J Cardiovasc Electrophysiol       Date:  2008-07-25

8.  Rising rates of hospital admissions for atrial fibrillation.

Authors:  Jens Friberg; Pernille Buch; Henrik Scharling; Niels Gadsbphioll; Gorm B Jensen
Journal:  Epidemiology       Date:  2003-11       Impact factor: 4.822

9.  Improvement in exercise capacity in asymptomatic and mildly symptomatic adults after atrial septal defect percutaneous closure.

Authors:  Marie-Claude Brochu; Jean-François Baril; Annie Dore; Martin Juneau; Pierre De Guise; Lise-Andrée Mercier
Journal:  Circulation       Date:  2002-10-01       Impact factor: 29.690

10.  Enalapril prevents perpetuation of atrial fibrillation by suppressing atrial fibrosis and over-expression of connexin43 in a canine model of atrial pacing-induced left ventricular dysfunction.

Authors:  Masao Sakabe; Akira Fujiki; Kunihiro Nishida; Masataka Sugao; Hidehiko Nagasawa; Takayuki Tsuneda; Koichi Mizumaki; Hiroshi Inoue
Journal:  J Cardiovasc Pharmacol       Date:  2004-06       Impact factor: 3.105

View more
  3 in total

1.  Inappropriate shocks from a transvenous implantable defibrillator caused by atrial fibrillation and a missed atrial septal defect in a patient with a modified Bentall procedure.

Authors:  Anna Kostopoulou; Epameinontas Fountas; Olga Karapanagiotou; Stamatis Kyrzopoulos
Journal:  Eur Heart J Case Rep       Date:  2021-10-07

2.  Single-cell RNA sequencing analysis to characterize cells and gene expression landscapes in atrial septal defect.

Authors:  Zunzhe Wang; Huating Wang; Ya Zhang; Fangpu Yu; Liwen Yu; Cheng Zhang
Journal:  J Cell Mol Med       Date:  2021-09-12       Impact factor: 5.310

3.  Challenges in Device Closure of Secundum Atrial Septal Defect in Older Patients in Their Fifth Decade and Beyond.

Authors:  Anil K Singhi; Soumya K Mahapatra; Dilip Kumar; Somnath Dey; Amiya Mishra; Arnab De
Journal:  Cureus       Date:  2022-02-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.